Zepbound sales keep soaring, even as weight loss drug growth slows
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s initial sales expectations.
Novo Nordisk Expects Slowing Sales Growth This Year
The Danish pharmaceutical company expects sales growth to slow this year as capacity constraints, intensifying competition and pricing pressure drag on sales of its blockbuster weight-loss and diabetes drugs.
Wegovy sales double to boost Novo Nordisk's fourth quarter as growth set to slow
Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the final quarter of 2024, with analysts and investors describing the results as "good enough" to ease nerves about stiff competition from rival Eli Lilly.
Novartis Expects Further Profit, Sales Growth Despite Competition Threat
The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart drug Entresto.
Danish Brewer Carlsberg Expects Lower Profit Growth in 2025
Carlsberg A/S expects more modest operating profit growth in 2025 after losing the license to produce San Miguel beer in the UK and as many markets remain challenging.
Danish brewer Carlsberg slightly misses on fourth-quarter sales, points to slower growth in 2025
Danish brewer Carlsberg on Thursday reported a slight miss in fourth-year sales and pointed to lower growth in 2025.
IBM Gives Long-Term Sales Growth Outlook That Tops Expectations
International Business Machines Corp. gave a stronger-than-expected revenue growth outlook for the coming years led by the ...
Yum Brands Projects Stronger Sales Growth This Year
Fast-food restaurant owner Yum Brands is expecting stronger sales growth this year after it moves past challenges in its Middle East markets.
AstraZeneca Expects Revenue, Earnings Growth Despite Sales Drop in China
Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...
Chipotle assesses fallout from Mexico tariffs, forecasts tepid annual sales growth
Chipotle Mexican Grill said on Tuesday that if President Donald Trump's proposed tariffs on Mexico go into full effect, the ...
Yum Brands Sales Turn Positive, Driven By Taco Bell Results
Yum! Brands Inc. sales surpassed expectations, powered by growth at Taco Bell as the fast-food chain continues to sidestep a slowdown that has plagued many competitors.
Gilead: Strong Sales Growth Remains With Veklury And Beyond
Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.
Alphabet shares tumble after revenue miss, cloud sales disappoint
Alphabet said on Tuesday it will spend $75 billion on its AI buildout this year, 29% more than Wall Street expected, and ...